Outset Medical (OM) to Release Quarterly Earnings on Wednesday

Outset Medical (NASDAQ:OM) is scheduled to be releasing its earnings data after the market closes on Wednesday, May 8th. Analysts expect Outset Medical to post earnings of ($0.60) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Outset Medical (NASDAQ:OM) last posted its quarterly earnings data on Wednesday, February 21st. The company reported ($0.77) earnings per share for the quarter, missing the consensus estimate of ($0.74) by ($0.03). Outset Medical had a negative return on equity of 102.50% and a negative net margin of 132.54%. The firm had revenue of $30.51 million for the quarter, compared to analyst estimates of $30.40 million. On average, analysts expect Outset Medical to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Outset Medical Trading Up 4.7 %

Shares of NASDAQ OM opened at $3.14 on Monday. The company has a debt-to-equity ratio of 1.06, a current ratio of 5.26 and a quick ratio of 4.37. The firm has a fifty day simple moving average of $2.48 and a 200 day simple moving average of $3.75. Outset Medical has a twelve month low of $1.92 and a twelve month high of $24.13.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on OM shares. Royal Bank of Canada downgraded Outset Medical from an “outperform” rating to a “sector perform” rating and dropped their price objective for the company from $14.00 to $6.00 in a research note on Friday, January 12th. BTIG Research assumed coverage on Outset Medical in a report on Monday, April 8th. They issued a “buy” rating and a $6.00 target price for the company. Finally, CL King upgraded Outset Medical from a “neutral” rating to a “buy” rating and set a $6.00 price target on the stock in a report on Friday, April 5th. One analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $5.42.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.